Published Articles & Presentations

Published Articles & Presentations

The information in our publications and presentations should be considered accurate only as of the date of the publications or presentations. We disclaim any obligation to supplement or update the information in these publications and presentations.

To learn more about our innovative technology:
A Long Term, Open Label Study of Safety and Tolerability of Precision Olfactory Delivery of DHE in Acute Migraine (STOP 301): Clinical Results

Selected as a live presentation at the 2020 Migraine Trust International Symposium Authors: Sheena Aurora, Maria Jeleva, Jasna Hocevar-Trnka, John Hoekman, Stephen Shrewsbury Introduction: Migraine is a common neurological disease impacting at least 12% of the US population. Despite several…

READ MORE

Does Dihydroergotamine Treat the “Whole Migraine”?

Presented at the 2020 Migraine Trust International Symposium Authors: Sheena Aurora, Sutapa Ray, Kelsey Satterly, Stephen Shrewsbury, John Hoekman Introduction: Migraine is recognized as a complex, multifactorial brain network disease associated with 40 different gene loci. Despite a growing body…

READ MORE

Patient Acceptability of a Novel Upper Nasal Delivery System for DHE – Using the Precision Olfactory Delivery (POD®) Device (INP104)

Presented at the 2020 Migraine Trust International Symposium Authors: Stephen Shrewsbury, Sheena Aurora, John Hoekman, Maria Jeleva Introduction: DHE is an effective acute treatment for episodic migraine, but from 1946–1996 was only available as an injection. Nasal DHE (Migranal® )…

READ MORE